Health
Moffitt researchers discover regulatory pathway that blocks immune response against cancer – EurekAlert
In a new article published in the journal Immunity, Moffitt Cancer Center researchers show that TIM-3 inhibits the STING signaling pathway in dendritic cells, thereby…
TAMPA, Fla. – A hallmark of cancer is its ability to evade the immune system. It is why researchers are focused on finding new strategies and targets to jumpstart the immune system so it can mount a response against tumors. One such target is the inhibitory receptor T-cell immunoglobulin and mucin domain 3 (TIM-3), a protein that is overexpressed in many different types of cancer and is associated with poor patient outcomes. It is known to block the activity of immune cells, such as dendritic cells,…
-
Noosa News22 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools
-
Noosa News20 hours agoMan charged with murder three days after death of 27-year-old in Livingstone, QLD
-
Business13 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News13 hours agoRent changes on way for hundreds of social housing recipients following government review